Accurate determination of resistance is important to ensure appropriate antimicrobial
therapy in Stenotrophomonas maltophilia infections. This study was undertaken to evaluate …

The antimicrobial treatment of Stenotrophomonas maltophilia infections is complicated by
intrinsic multidrug resistance and a lack of reliable susceptibility data. We assessed the …

Purpose Stenotrophomonas maltophilia has low pathogenicity potential, but if it causes
bacteremia it can be fatal, because it has shown high resistance to many antibiotics and can …

Severe infections caused by Stenotrophomonas maltophilia are associated with high
mortality, and strategies to improve the clinical outcome for infected patients are needed. A …

Susceptibility to 41 antimicrobials was studied with 99 Stenotrophomonas maltophilia
strains, and different pulsed-field gel electrophoresis profiles were identified among 130 …

Abstract Background Treatment options for Stenotrophomonas maltophilia (S. maltophilia)
infections were limited. We assessed the efficacy of ceftazidime (CAZ), ceftazidime …

Stenotrophomonas maltophilia is an emerging global opportunistic pathogen, responsible
for a wide range of human infections, including respiratory tract infections. Intrinsic multidrug …

Aims: Aim of the study is to identify accurately Stenotrophomonas maltophilia isolates
recovered from environmental and clinical samples. Methods and Results: Recovery of Sten …

A retrospective study was performed in a university-affiliated referral center from year 1999
to year 2004 to understand the trend of resistance in Stenotrophomonas maltophilia isolates …

Abstract Background Trimethoprim-sulfamethoxazole (TMP-SMX) is considered first-line
therapy for Stenotrophomonas maltophilia infections based on observational data from small …